Pyrazolo[1,5-a]pyridine-3-carboxylic acid, 7-bromo-4-fluoro-, ethyl ester

Pyrazolo[1,5-a]pyridine-3-carboxylic acid, 7-bromo-4-fluoro-, ethyl ester (CAS: 2387596-83-8) is a highly functionalized halogenated pyrazolo[1,5-a]pyridine derivative widely used in medicinal chemistry, heterocyclic scaffold development, and pharmaceutical lead discovery. Featuring a fused pyrazolo–pyridine core with strategically positioned bromine and fluorine substituents and an ethyl ester functional group, it provides a versatile pharmacophore platform for electronic tuning, cross-coupling diversification, and bioactive molecule construction. The compound is primarily employed in kinase inhibitor discovery, structure-based drug design, and structure–activity relationship (SAR) optimization, supporting hit identification, lead optimization, and preclinical candidate development. Its primary applications are outlined below:

1. Medicinal Chemistry & Drug Discovery

Kinase Inhibitor Scaffold Development

This compound serves as a privileged heteroaromatic scaffold in ATP-competitive kinase inhibitor design. The fused pyrazolo[1,5-a]pyridine core enables strong hinge-region binding through hydrogen bonding interactions, while halogen substitution enhances target affinity and binding pocket complementarity. Researchers utilize it in oncology, immunology, and inflammatory disease-related kinase programs.

Lead Optimization in Drug Development Pipelines

The ethyl ester functionality provides a convenient synthetic handle for hydrolysis, amidation, or ester modification, enabling systematic exploration of pharmacokinetic and pharmacodynamic properties. Medicinal chemists apply this scaffold in hit-to-lead and lead optimization workflows to improve potency, selectivity, and metabolic stability.

2. Structure–Activity Relationship (SAR) Exploration

Halogen-Driven Electronic Modulation Studies

The presence of bromine and fluorine atoms allows fine-tuning of electronic density, lipophilicity, and steric interactions. Researchers use this compound to investigate how halogen substitution patterns influence receptor binding affinity, selectivity profiles, and off-target interactions.

Scaffold Diversification Platform

The bromine substituent provides a reactive site for Suzuki, Buchwald–Hartwig, and other cross-coupling reactions, enabling rapid generation of chemical libraries. This makes the compound highly valuable in diversity-oriented synthesis and fragment expansion strategies.

3. Chemical Biology & Mechanistic Research

Target Engagement and Binding Mode Analysis

The rigid fused heteroaromatic framework is used in molecular docking, crystallography-guided design, and target engagement studies to evaluate binding orientation within kinase active sites and other ATP-dependent enzymes.

Signal Transduction Pathway Modulation Studies

Researchers apply derivatives of this scaffold to probe intracellular signaling pathways involved in cell proliferation, differentiation, apoptosis, and immune regulation, particularly in disease-relevant kinase networks.

4. Pharmaceutical Process Development

Synthetic Intermediate for Scalable Routes

The compound is utilized in process chemistry as a key intermediate for evaluating scalable synthetic routes to complex heterocyclic drug candidates. Its defined substitution pattern supports reproducibility and route optimization in multi-step synthesis.

Analytical Standard for Quality Control

It is used in LC-MS and HPLC method development for impurity profiling, stability testing, and quality assurance of pyrazolo-based drug substances and intermediates.

5. Library Design & High-Throughput Screening

Bioactive Screening Library Component

This compound is frequently incorporated into kinase-focused and heterocycle-enriched screening libraries due to its drug-like properties and privileged scaffold status, supporting hit identification in high-throughput screening (HTS) campaigns.

Fragment-Based Drug Design (FBDD) Utility

Its compact yet highly functionalized heterocyclic structure makes it suitable for fragment growth strategies, enabling systematic optimization into high-affinity lead compounds.

6. Handling & Storage

Storage Conditions

Store in tightly sealed containers under dry, cool (2–8 °C), and dark conditions. Protect from moisture and prolonged light exposure, particularly due to the presence of halogenated aromatic and ester functionalities that may be sensitive to hydrolysis over time.

Intended Use

This compound is intended strictly for laboratory research use, including medicinal chemistry, chemical biology, and pharmaceutical R&D applications. It is not intended for therapeutic or diagnostic use in humans or animals without regulatory authorization. Standard laboratory safety practices and protective equipment should be followed during handling.

Summary

The value of Pyrazolo[1,5-a]pyridine-3-carboxylic acid, 7-bromo-4-fluoro-, ethyl ester lies in its highly versatile halogenated heteroaromatic scaffold, offering strong kinase-binding potential, tunable electronic properties, and robust synthetic flexibility. Its cross-coupling compatibility, pharmacophore richness, and structure rigidity make it an important intermediate in kinase inhibitor development, SAR exploration, and modern medicinal chemistry research. The compound supports hit identification, lead optimization, and next-generation drug discovery programs targeting complex disease pathways.

For more information, please contact: selina@coreychem.com